A 2001 Genentech Patent Is Revoked
690099
The decision could cost Genentech millions in royalties over the next decade but would save a like amount for rivals that are paying the royalties.
224419
(InfoWorld) - A day after winning a patent infringement lawsuit against a Taiwanese memory chip maker Japan's Fujitsu Ltd. has filed to have the chips in question barred from Japan. TheÂ Tokyo District Court Thursday upheld Fujitsu claims that DRAM (dynamic RAM) memory chips made by Nanya Technology Corp. infringed upon patents held by Fujitsu. The court granted an injunction against future import and sales of the chips. Fujitsu said Friday it had filed an application with Japan's customs authority to suspend import of the DRAM chips under the country's customs law. The lawsuit concerned a patent related to a technology for improving the speed of DDR SDRAM (double data rate synchronous dynamic RAM) memory chips and was filed just over two years ago after talks between the two companies produced no agreement on patent licensing. "We've been in IP discussions [with Fujitsu] for a while. It's regretful that we have not reached an agreement yet," said Pai Pei-lin, vice president of sales at Nanya Technology Corp. The case with Fujitsu probably won't have much impact on Nanya in the near term, he said, because it's been going on for a while and the company has already made contingency plans. Nanya will most likely appeal the decision, but company lawyers will have to take a close look at the ruling before making such a decision, he said. Nanya is fighting a similar case with Fujitsu in the U.S., but the proceedings there look more favorable for Nanya than the Japan ruling, he added. Â
40500
An appeals court should throw out a half-billion-dollar patent infringement judgment against Microsoft because a lower court failed to recognize that the Web browsing patent was based on a technology that was not invented by the company awarded the money
225228
BOSTON (CBS.MW) - Shares of Genentech were halted on Monday as the company announced that its oncology drug Avastin had been shown to extend the lives of some patients stricken with advanced colorectal cancer.
83329
Blog: Google loses appeal of Gmail trademark case in Germany.
40243
The printer maker's courtroom setback may mean consumer electronics companies won't try to use the Digital Millennium Copyright Act as an all-purpose competition shield anymore. By Katie Dean.
54701
Microsoft is applying for a patent for an operating system that starts out crippled.  You must pay to do things like take the throttle off network speed, disk access, install drivers, install software, and more.  Trust me, I rarely even visit Groklaw, even if this is my second consecutive blog entry with a link to a Groklaw article. My VarLinux.org readers posted the article, A Brave New Modular World, and I had to share it.
709547
Swiss drugmaker Roche&#39;s (ROG.VX: Quote, Profile, Research) majority-owned biotech firm Genentech Inc (DNA.N: Quote, Profile, Research) faces an investigation by US
658871
Boston Scientific Corp. , the medical device maker, eliminated 55 jobs in Marlborough last month, according to the state Executive Office of Labor and Workforce Development. Company spokesman Paul Donovan said the Natick firm made the cuts after deciding to pull the plug on its Endovations program, an effort to develop a new single-use endoscope with an integrated ...
75723
Genentech appears to have resolved a dispute with ophthalmologists over use of  the companyâs drug Avastin   to treat eye diseases.
763548
Shares in Repligen Corp. fell nearly 18 percent yesterday after the Waltham biotech company settled a patent suit with ImClone Systems Inc. for less than some investors expected. Under terms of the deal, ImClone agreed to pay $65 million to end the case.
261833
The U.S. scientist who ran a gene  therapy study that ended with the death of an 18-year-old is  barred from leading human research trials for five years under  a settlement with the government, the Justice Department said  on Wednesday.
593834
Genentech's stock is even more expensive than you think.
686996
After two weeks of almost incessant bad news for Microsoft comes a ray of hope, courtesy of US District Court in San Diego: Judge Rudi Brewster has dismissed a series of patent infringement claims against Microsoft regarding technology Bell Laboratories developed for converting text into speech, in a summary judgment this afternoon.
230281
Merck received yet another blow when a court unexpectedly invalidated a patent on Fosamax, an osteoporosis treatment that is Merck's second-best-selling drug.
749737
American biotechnology firm Amgen yesterday lost its right to produce a billion-dollar anaemia drug, Epogen, exclusively in the UK after a House of Lords ruling.
53769
SOUTH SAN FRANCISCO, Calif. -- Biotechnology company Genentech Inc. received a subpoena from the US Attorney&#39;s Office for the Eastern District of Pennsylvania requesting documents related to the promotion